Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
76.22 USD | +0.58% | +0.17% | +8.05% |
04-17 | ReNeuron Group Reports CFO Resignation | MT |
04-17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Sales 2024 * | 914M 1.25B | Sales 2025 * | 984M 1.34B | Capitalization | 1.59B 2.17B |
---|---|---|---|---|---|
Net income 2024 * | 74M 101M | Net income 2025 * | 77M 105M | EV / Sales 2024 * | 1.74 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
20.7
x | Employees | 849 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.85% |
1 day | +0.58% | ||
1 week | +0.17% | ||
Current month | -0.92% | ||
1 month | +1.97% | ||
3 months | +11.90% | ||
6 months | +33.84% | ||
Current year | +8.05% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Hawkins
CEO | Chief Executive Officer | 53 | 91-12-31 |
Director of Finance/CFO | 51 | 17-04-30 | |
Drew Grahek
COO | Chief Operating Officer | 54 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Thompson
CHM | Chairman | 73 | 08-12-31 |
Mary Schumacher
BRD | Director/Board Member | 67 | 11-12-31 |
Jeffrey Wright
BRD | Director/Board Member | 61 | 08-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.65% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 76.09 | +0.41% | 7 915 |
24-04-26 | 75.78 | +1.05% | 54,763 |
24-04-25 | 74.99 | -2.86% | 120,540 |
24-04-24 | 77.2 | +0.32% | 64,871 |
24-04-23 | 76.95 | +1.30% | 66,331 |
Delayed Quote Nasdaq, April 29, 2024 at 11:32 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.05% | 1.59B | |
-0.19% | 74.89B | |
+0.56% | 46.52B | |
-4.13% | 30.82B | |
+11.27% | 18.19B | |
-9.54% | 11.54B | |
+8.53% | 11.24B | |
-7.33% | 9.73B | |
+2.79% | 9.4B | |
+6.33% | 9.37B |
- Stock Market
- Equities
- HWKN Stock